MERCK Kommanditgesellschaft auf Aktien Stock Other OTC
Equities
MKKGY
US5893392093
Pharmaceuticals
Sales 2024 * | 21.31B 23.16B | Sales 2025 * | 22.58B 24.54B | Capitalization | 66.67B 72.45B |
---|---|---|---|---|---|
Net income 2024 * | 2.99B 3.25B | Net income 2025 * | 3.53B 3.84B | EV / Sales 2024 * | 3.43 x |
Net Debt 2024 * | 6.44B 7B | Net Debt 2025 * | 4.63B 5.03B | EV / Sales 2025 * | 3.16 x |
P/E ratio 2024 * |
22.4
x | P/E ratio 2025 * |
18.7
x | Employees | - |
Yield 2024 * |
1.52% | Yield 2025 * |
1.67% | Free-Float | 29.71% |
Latest transcript on MERCK Kommanditgesellschaft auf Aktien
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 20-07-12 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 14-07-31 |
Director of Finance/CFO | 54 | 19-04-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Jürgen Glaser
BRD | Director/Board Member | 61 | 12-04-30 |
Gabriele Eismann
BRD | Director/Board Member | 62 | 90-12-31 |
1st Jan change | Capi. | |
---|---|---|
+30.84% | 10.12B | |
+28.34% | 4.83B | |
-20.02% | 4.53B | |
+18.94% | 3.59B | |
+22.06% | 2.18B | |
-36.80% | 1.8B | |
-42.53% | 1.74B | |
-0.50% | 1.64B | |
-1.55% | 1.51B |